Authors/Disclosures
|
|
No disclosure on file |
|
Renato P. Munhoz, MD, PhD
|
Dr. Munhoz has nothing to disclose. |
|
Analia Calle
|
Analia Calle has nothing to disclose. |
|
Helio Afonso G. Teive, MD, PhD, FAAN
|
Dr. Teive has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Tetsuo Ashizawa, MD, FAAN
(Methodist Hospital Research Institute)
|
An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen. |
|
Andrew J. Lees, MD, FRCP
(Reta Lila Weston Institute of Neurological Studies, IoN, UCL)
|
Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Britannia. Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Bial Pharma. |
|
|
No disclosure on file |